Does DINOPROSTONE Cause Off label use? 52 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 52 reports of Off label use have been filed in association with DINOPROSTONE (CERVIDIL). This represents 7.2% of all adverse event reports for DINOPROSTONE.
52
Reports of Off label use with DINOPROSTONE
7.2%
of all DINOPROSTONE reports
1
Deaths
25
Hospitalizations
How Dangerous Is Off label use From DINOPROSTONE?
Of the 52 reports, 1 (1.9%) resulted in death, 25 (48.1%) required hospitalization, and 3 (5.8%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DINOPROSTONE. However, 52 reports have been filed with the FAERS database.
What Other Side Effects Does DINOPROSTONE Cause?
Foetal exposure during pregnancy (67)
Uterine hyperstimulation (65)
Premature separation of placenta (48)
Maternal exposure during pregnancy (46)
Postpartum haemorrhage (40)
Premature baby (40)
Drug ineffective (36)
Foetal heart rate deceleration abnormality (36)
Premature delivery (33)
Exposure during pregnancy (32)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which DINOPROSTONE Alternatives Have Lower Off label use Risk?
DINOPROSTONE vs DINUTUXIMAB
DINOPROSTONE vs DINUTUXIMAB BETA
DINOPROSTONE vs DIOSMIN
DINOPROSTONE vs DIOSMIN\HESPERIDIN
DINOPROSTONE vs DIOVAN